From October 1, 2023 to October 4, 2023, the company has repurchased 75,109 shares, representing 0.09% for $0.17 million. With this, the company has completed the repurchase of 3,132,012 shares, representing 3.96% for $5.98 million under the buyback announced on November 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.93 USD | +0.52% | -10.23% | -12.67% |
20/05 | Standard BioTools Receives Shareholder Proposal from Madryn Asset Management | CI |
08/05 | Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.67% | 714M | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B | |
+19.65% | 30.23B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on November 28, 2022.